Blueclinical Expands Business with Viedoc to Accelerate Bioequivalence and Early-Stage Clinical Studies
BlueClinical recognized by Agência Nacional de Inovação (ANI) as an idoneous entity for conducting R&D activities in the field of translational research
BlueClinical is a founding member of the new pan-European CRO Astrum. For more information about the new range of available services, visit the new Company's website at www.astrumcro.com.